Patent details

Basic Information

Publication number:

EP2830642

PCT Application Number:

US2013031662

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP137696241

PCT Publication Number:

WO2013148277

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

SUBCUTANEOUS ADMINISTRATION OF IDURONATE- 2-SULFATASE

French Title of Invention:

ADMINISTRATION SOUS-CUTANÉE D'IDURONATE 2-SULFATASE

German Title of Invention:

SUBKUTANE VERABREICHUNG VON IDURONAT-2-SULFATASE

SPC Number:

Dates

Filing date:

14/03/2013

Grant date:

28/08/2019

EP Publication Date:

04/02/2015

PCT Publication Date:

03/10/2013

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

28/08/2019

EP B1 Publication Date:

28/08/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

14/03/2020

Expiration date:

14/03/2033

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

21/08/2019

 

 

Name:

Shire Human Genetic Therapies, Inc.

Address:

300 Shire Way, Lexington MA 02421, United States (US)

Inventor

1

Name:

MCCAULEY, Thomas

Address:

United States (US)

2

Name:

XIE, Hongsheng

Address:

United States (US)

3

Name:

FELICE, Brian

Address:

United States (US)

Priority

Priority Number:

201261618638 P

Priority Date:

30/03/2012

Priority Country:

United States (US)

Classification

IPC classification:

A61K 38/00; A61K 38/43; A61P 25/00;

Publication

European Patent Bulletin

Issue number:

201935

Publication date:

28/08/2019

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages